Boston, Massachusetts, USA – May 15, 2025 – ArisGlobal, an innovative technology company at the forefront of life sciences and creator of the LifeSphere® Unify platform, today announced the appointment of Lucinda Smith as Chief Safety Product Officer. Lucinda will lead the strategic direction and innovation of ArisGlobal’s safety product suite, helping to accelerate the company’s investment in next-generation automation and AI-powered solutions that deliver measurable ROI to global pharmaceutical organizations.
Lucinda joins ArisGlobal with over two decades of experience in pharmacovigilance and drug safety operations. Most recently, she served as Global Head of Safety Operations at Roche, where she spearheaded enterprise-wide programs focused on innovation, transformation, and change management—including the successful implementation of LifeSphere MultiVigilance, ArisGlobal’s industry-leading safety case management system.
“Lucinda’s unique perspective as both a PV leader and a longtime advocate of advanced technology makes her an ideal choice to lead ArisGlobal’s Safety product strategy,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal. “As we continue to bring NavaX™-enabled innovation to market—such as our newly launched NavaX Agents and Advanced Compliance Docs—Lucinda’s leadership will be essential in ensuring these solutions deliver real-world impact and ROI for our customers.”
“Having worked with LifeSphere solutions first-hand, I know just how powerful, effective, and trusted these products are across the industry,” said Lucinda Smith, Chief Safety Product Officer. “ArisGlobal’s ongoing investment in product innovation—especially in automation and applied AI—is unmatched. I’m excited to be part of a world-class team that’s driving true transformation in pharmacovigilance and helping customers improve patient safety, reduce cost, and scale their operations with confidence.”
This new leadership appointment comes as ArisGlobal builds momentum across its product portfolio, with the recent launch of several NavaX-enabled solutions including Advanced Compliance Docs, NavaX Insights, and NavaX Agents, further solidifying the company’s commitment to delivering AI-powered innovation with tangible benefits for the life sciences industry.
